Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy

MLA

Samuel W. Terman, et al. “Antiseizure Medication Treatment Pathways for US Medicare Beneficiaries with Newly Treated Epilepsy.” Epilepsia, vol. 63, Mar. 2022, pp. 1571–79. EBSCOhost, https://doi.org/10.1111/epi.17226.

APA

Samuel W. Terman, Brett E. Youngerman, Hyunmi Choi, & James F. Burke. (2022). Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy. Epilepsia, 63, 1571–1579. https://doi.org/10.1111/epi.17226

Chicago

Samuel W. Terman, Brett E. Youngerman, Hyunmi Choi, and James F. Burke. 2022. “Antiseizure Medication Treatment Pathways for US Medicare Beneficiaries with Newly Treated Epilepsy.” Epilepsia 63 (March): 1571–79. doi:10.1111/epi.17226.